A small proportion of CH patients are resistant to thyroid hormone because of mutations in THRA (12) or THRB (13, 14), which encode thyroid hormone receptors or mutations in SLC26A2 (15, 16), which encodes the thyroid hormone transporter, thereby decreasing the sensitivity of target tissues to thyroid hormone action. This evidence concerns the gene THRA and cyclic hematopoiesis.